Vanguard Russell 2000 ETF (VTWO)

Small-cap stocks have underperformed mid- and large-cap stocks over the years.

You don't need to spend hours researching stocks to build a nest egg.

United States Antimony Corp. garnered retail interest on Monday as the ongoing war in Iran, and its recent uplisting to the New York Stock Exchange fueled investor optimism.

Energy Secretary Chris Wright directed Sable Offshore Corp. to begin restoring operations for the Santa Ynez Unit and Santa Ynez Pipeline System in California, Bloomberg News report said.

DMRC’s total revenue for the fourth quarter of 2025 was $8.9 million compared to $8.7 million for the fourth quarter of 2024.

America's small-cap stocks are benefiting from favorable domestic policies, falling interest rates, and more.

Rosenblatt lowered the firm's price target on Webull to $12 from $15 and kept a ‘Buy’ rating on the shares, per TheFly.

The company posted net income per ordinary share of $0.01 that was below Wall Street estimates of $0.05 per share as per data from Fiscal.ai.

The U.S. and Israel’s attack on Iran over the weekend, and retaliatory strikes by Iran in the Gulf region has put defense-related stocks in focus, with several rallying in anticipation that the war is expected to last weeks.

Aurinia reported adjusted earnings per share of $1.53 on revenue of $77.1 million, while Wall Street analysts expected an adjusted EPS of $0.22 on revenue of $74.7 million, according to Koyfin data.

The Russell 2000 certainly represents the most comprehensive way to invest in small caps, but it's important to know exactly what you're buying.

For years, small caps have been ignored. Today, they have one of the best value and growth profiles in the market.

The small-cap Russell 2000 index is benefiting from the U.S. government's focus on domestic industries.

Vanguard Russell 2000 is a high-quality ETF, but you can find a winner within its portfolio that can beat the fund in 2026 and beyond.

With small-caps strutting their stuff to start 2026, this ETF may be garnering more attention, but investors can do better.

According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.

I was extremely bullish on small-cap stocks at the start of 2025, but the S&P 500 outperformed once again.

Small-caps are off to a fast start in 2026. Is now the time to jump into the Russell 2000 again?

These four ETFs cover a lot of ground and don't require much in-depth research before purchasing.

Tech remains a popular investing choice heading into 2026. I see a few other areas of the market that investors should be watching instead.

I'm planning to focus on ETFs in 2026, and these are on the top of my buy list.

Large caps and tech stocks have dominated the market over the past three years. Is now the time for a small-cap comeback?

This exchange-traded fund's performance has been strangely weak for a while now, but this might just spell opportunity.

I own about four dozen stocks, but these 10 represent about 44% of my portfolio's value.